About
Cormedix Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 27 2026
CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients
Apr 7 2026
CorMedix to Participate in Needham Virtual Healthcare Conference
Mar 5 2026
CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Mar 2 2026
CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026
Feb 2 2026
CorMedix Therapeutics Announces Share Repurchase Program
Translate